TransAct Technologies Incorporated designs, develops, and markets transaction-based and specialty printers and terminals in the United States and internationally. It offers thermal printers and terminals to generate labels, coupons, and transaction records, such as receipts, tickets, and other documents. The company also provides consumable products, including POS receipt paper, ribbons, and other printing supplies, as well as replacement parts and accessories; and maintenance and repair services. In addition, it offers EPICENTRAL print system, a software solution that enables casino operators to create promotional coupons and marketing messages, and print them at the slot machine; and technical support services, as well as spare parts and accessories. Further, the company provides BOHA! terminal that combines hardware and software components in a device that includes an operating system, touchscreen, and one or two thermal print mechanisms. It markets its products under the TransAct, BOHA!, AccuDate, Epic, Ithaca, and EPICENTRAL brands for food service technology, point of sale automation, and casino and gaming markets. The company sells its products to original equipment manufacturers, value-added resellers, and distributors, as well as directly to end-users through its webstore transactsupplies.com. The company was incorporated in 1996 and is headquartered in Hamden, Connecticut.…
What TransAct Technologies (TACT) Said on Its Q3 Earnings Call
TransAct Technologies (NASDAQ: TACT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Computer Hardware industry, part of the Technology sector, and reports about 103 employees.
The shares were at 4.520 USD on 20 November 2026, up 3.9% over 52 weeks. Its 52-week range is 3.060 USD to 6.021 USD: the price is 24.9% below the high and 47.7% above the low.
Its market capitalisation is 46.73M USD.
TransAct Technologies reports return on equity of -4.0%, an operating margin of -1.6% and revenue up 9.6% year over year.
It holds more cash than debt, a net cash position of 14.11M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 7.000 USD is 54.9% above the current price. The next earnings report is expected on 9 March 2027.